Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orlistat

REVIVE

Empros Pharma AB · Phase 2 · Terminated · Enrollment 128

NCT01351753

ArmPopulationDoseWeeksEstimandWeight change
MetforminObesity or overweightn/rn/rn/rn/r
Metformin + OrlistatObesity or overweightn/rn/rn/rn/r
Metformin + TopiramateObesity or overweightn/rn/rn/rn/r
TopiramateObesity or overweightn/rn/rn/rn/r
Metformin + Topiramate + OrlistatObesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r